These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17374017)

  • 1. Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil.
    Takehara Y; Igawa K; Satoh T; Yokozeki H
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):577-8. PubMed ID: 17374017
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid drug eruption to terazosin.
    Koh MJ; Seah PP; Tay YK; Mancer K
    Br J Dermatol; 2008 Feb; 158(2):426-7. PubMed ID: 18047505
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasma-cytoid dendritic cells.
    Park JJ; Choi YD; Lee JB; Kim SJ; Lee SC; Won YH; Yun SJ
    Acta Derm Venereol; 2010 May; 90(3):305-6. PubMed ID: 20526555
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous eruption due to indoramin.
    Farrell AM; Bunker CB
    Clin Exp Dermatol; 1998 Sep; 23(5):233. PubMed ID: 10233611
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasiform eruption induced by captopril and chlorthalidone.
    Wolf R; Dorfman B; Krakowski A
    Cutis; 1987 Aug; 40(2):162-4. PubMed ID: 2957174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasiform cutaneous eruptions induced by cetamolol hydrochloride.
    White WB; Schulman P; McCabe EJ
    Arch Dermatol; 1986 Aug; 122(8):857-8. PubMed ID: 2874772
    [No Abstract]   [Full Text] [Related]  

  • 7. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.
    Yamamoto M; Ikeda M; Kodama H; Sano S
    J Dermatol; 2008 Nov; 35(11):732-6. PubMed ID: 19120769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasiform fixed drug eruption caused by nimesulide.
    Katoulis AC; Bozi E; Kanelleas A; Makris M; Alevizou A; Panagiotides I; Stavrianeas NG
    Clin Exp Dermatol; 2009 Oct; 34(7):e360-1. PubMed ID: 19486051
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
    Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
    Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical efficacy and safety of naftopidil 75 mg on benign prostatic hyperplasia patients with moderate or severe urinary disturbance].
    Tsujihata M; Yoshimura K; Kojima Y; Oda M; Miyake O; Uchida K; Okuyama A
    Hinyokika Kiyo; 2009 Apr; 55(4):181-6. PubMed ID: 19462821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psoriasis and beta-blockade].
    Steinkraus V; Mensing H
    Hautarzt; 1992 Apr; 43(4):179-83. PubMed ID: 1350775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasiform drug eruption associated with metformin hydrochloride: a case report.
    Koca R; Altinyazar HC; Yenidünya S; Tekin NS
    Dermatol Online J; 2003 Aug; 9(3):11. PubMed ID: 12952758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paradoxical psoriasiform eruption due to abatacept (ORENCIA(®))].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Dec; 139(12):871-2. PubMed ID: 23237294
    [No Abstract]   [Full Text] [Related]  

  • 17. A Probable Case of Mucosal Fixed Drug Eruption Following Treatment with Silodosin.
    Klimi E
    Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e402-e404. PubMed ID: 30607288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasiform Eruption Secondary to the Use of Adalimumab.
    Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
    J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Hayase M; Hayashi Y; Shinoura H; Tsujimoto G; Kohri K
    J Urol; 2008 Mar; 179(3):1040-6. PubMed ID: 18206918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.